Syschem India Ltd. · BSE:SYSCHEM
Syschem India — Investor Presentation (May 2026)
32 slides from Syschem India's investor presentation, May 30, 2026
Slide 1: Investor Pitch Deck
INVESTOR PITCH DECK ~INNOVATING TODAY FOR A HEALTHIER TOMORROW
Slide 2: Agenda
AGENDA Corporate Identity 03-10 Production 11-13 Financials 14-22 Governance & Sustainability 24-33 Investor Presentation, 2026
Slide 3: Corporate Identity
CORPORATE IDENTITY www.syschem.in Investor Presentation, 2026
Slide 4: About Us
ABOUT US Syschem (India) Limited (SIL) is a listed company engaged in the manufacturing of Bulk Drugs/Intermediates and contract manufacturing. It is owned and operated by a highly committed group of techno commercial with extensive experience in the bulkdrug business. The Company is committed to it
Slide 5: Mission & Vision
MISSION & VISION The company aims to become one of To become a leading and trusted India’s leading manufacturers of APIs global partner in the API industry and pharmaceutical intermediates by creating long-term value for all by providing high-quality, stakeholders through innovation, innovative, and
Slide 6: Our Business Strategy
OUR BUSINESS STRATEGY Reliable Supply Continuous Innovation Syschem India Limited operates a resilient and Syschem drives sustainable growth through scalable supply chain backed by integrated continuous investments in R&D, process manufacturing, disciplined capacity planning, engineering, and produc
Slide 7: Foundation
FOUNDATION Operational Market Reach & Leadership Financial Strength Infrastructure & Geographic Capability & & Sustainability Scalability Expansion Strategic Direction INSTALLED CAPACITY 200+ CONSUMERS SIL IS LED BY AN REVENUE GROWTH OF 70% OF ~ 4200 TPA AND TRADERS EXPERIENCED MANAGEMENT IN COMPARI
Slide 8: Growth & Capacity Expansion
GROWTH & CAPACITY EXPANSION MANUFACTURING EXPANSION WORKFORCE GROWTH QUALITY COMPLIANCE Development of dedicated Employee strength increased Focused on achieving Amoxicillin and other products like by 17%, supporting operational WHO-GMP certification to Cloxacillin sodium , Flucloxacillin expansion
Slide 9: Our Key Products
KEY PRODUCTS 01 Amoxicillin T/H Amoxicillin is a widely used antibiotic belonging to the penicillin group of antibiotics. 02 Ampicillin T/H Ampicillin is a type of antibiotic that is commonly used to treat bacterial infections. 03 Flucloxacillin Sod. Flucloxacillin is a type of antibiotic that is co
Slide 10: Supply Zone
GEOGRAPHICAL PRESENCE SUPPLY ZONE 52% The Company has a diverse range of APIs in the pharmaceuticals industry that are created chemically. The company has established a foothold in India and the international market. Syschem's expansive supply chain network is a testament to its commitment to excell
Slide 11: Supply Zone: Top 12 Export Destinations
GEOGRAPHICAL PRESENCE 34% SUPPLY ZONE Afghanistan Bangladesh China Nepal Expanding operations and improving Thailand Uganda Cambodia customer satisfaction are core goals for Kenya any thriving business. As we continue to Congo Sri Lanka grow, our focus remains on understanding and anticipating the n
Slide 12: Production
SYSCHEM INDIA PRODUCTION www.syschem.in
Slide 13: Production Volume FY25-26
PRODUCTION VOLUME FY25-26 FY 25-26 60% 820 MT 85% 1239 MT 463 MT 49% 497 MT QUARTER 1 QUARTER 2 QUARTER 3 QUARTER 4 Syschem India Ltd. demonstrated strong operational momentum with production volumes increasing from 463 MT in Q1 to 1,239 MT in Q4, reflecting significant capacity ramp-up and enhanced
Slide 14: Production FY 24-25 v/s FY 25-26
PRODUCTION FY 24-25 v/s FY 25-26 41% 1280 MT 85% 3039 MT FY 24-25 FY 25-26 Investor Presentation, 2025
Slide 15: Financials
INDIA FINANCIALS www.syschem.in
Slide 16: Financial Overview
FINANCIAL OVERVIEW 1.6% 3.2% TOTAL REVENUE EBITDA 655 Cr. 21.11 Cr. TOTAL REVENUE EBITDA PAT 17.08 Cr. 10.93 Cr. YOY EBITDA GROWTH PAT 95.2% FY 25-26 Syschem India Ltd. achieved a robust financial performance with ₹655 Cr in revenue, ₹21.11 Cr EBITDA, and ₹10.93 Cr PAT, reflecting strong operational
Slide 17: Sales Previous v/s Current Fiscal Year
SALES PREVIOUS V/S CURRENT FISCAL YEAR FY24-25 FY25-26 Figures in Rs.Lakhs Figures in Rs.Lakhs Quarter 1 Quarter 2 Quarter 3 Quarter 3 Quarter 4 Quarter 4 Quarter 1 Quarter 2 12000 14000 25000 13875 12000 10000 20000 24830 10000 10215 8000 15000 8000 16164 9113 6000 6000 10000 12675 11792 4000 5420
Slide 18: Domestic v/s Export
DOMESTIC V/S EXPORT FY25-26 (Figures with GST and Excise) FY24-25 (Figures without GST and Excise) Figures in Rs.Lakhs Domestic Export 50000 Domestic Export 45622 25000 24125 40000 20000 30000 15000 19839 20000 10000 9089 10000 5000 0 0 Domestic Export Domestic Export Export SALES :- 19839 Lacs Expo
Slide 19: Financials: PAT
FINANCIALS Figures in Rs.Lakhs Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 60 500 50 46 FY24-25 FY25-26 40 417 1200 400 20 14 1000 300 0 800 -20 200 190 600 167 174 -40 400 100 -60 200 -64 -80 0 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 FY24-25 FY25-26 FY 24-25 FY 25-26 FY 24-25 Q1 Q1 PAT :- 46.00 PAT :- 13.67 PAT :- 167.35 Q2 Q2 PAT
Slide 20: Financials: EBITDA
FINANCIALS Figures in Rs.Lakhs Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 1000 200 FY24-25 FY25-26 2500 800 150 2000 600 1500 100 400 1000 50 200 500 0 0 0 Q1 Q2 Q3 Q4 FY24-25 FY25-26 Q1 Q2 Q3 Q4 FY 24-25 FY 25-26 FY 24-25 Q1 Q1 EBITDA :- 403.2 EBITDA : 81.86 EBITDA :- 246.93 EBITDA MARGIN% : 1.04% Q2 Q2 EBITDA :- 6.8
Slide 21: Financials: Sales FY24-25 vs FY25-26
FINANCIALS Figures in Rs.Lakhs 50000 FY24-25 40631 40000 2024 SALES :- 38623 Lacs 30000 24748 20000 FY25-26 2025 SALES :- 65462 Lacs 10000 0 FY24-25 FY25-26 Syschem India Ltd. delivered strong topline growth, with revenue increasing from ₹386.23 Cr in FY 2024–25 to ₹654.62 Cr in FY 2025–26, reflecti
Slide 22: Financial Abouts
FINANCIAL ABOUTS Revenue Expansion 01 02 EBITDA Growth Company recorded a strong 70% EBITDA surged by 423%, driven by higher increase in revenue in FY 2025–26 volumes, improved product mix, and enhanced compared to FY 2024–25, reflecting operating efficiencies, demonstrating rapid scale-up in operat
Slide 23: Balance Sheet: Q4 and Q3 YoY Comparison
BALANCE SHEET Figures in Rs.Lakhs Particulars Q4 FY24-25 Q4 FY25-26 YoY% incr. Q3 FY24-25 Q3 FY25-26 YoY% incr. 16164 Financial Performance Comparison: Revenue From Operations 13875 24830.19 78.9% 9112.6 77% Q4 FY 2025–26 marks a defining EBITDA 191.66 936.74 389% 122.05 596.32 388% quarter for Sysc
Slide 24: Balance Sheet: QoQ and YoY Comparison
BALANCE SHEET Figures in Rs.Lakhs Particulars Q3 FY25-26 Q4 FY25-26 QoQ% incr. FY24-25 FY25-26 YoY% incr. Revenue From Operations 16164 24830.19 53.6% 38624 65464.70 70% EBITDA 596.32 936.74 38% 403.2 2111.38 423% EBITDA Margin% 3.7% 3.77% 1.8% 1.043% 3.22% 210% Other Income 0.161 0.36 4.24 2.1 Depr
Slide 25: Governance & Sustainability
GOVERNANCE & SUSTAINABILITY www.syschem.in Investor Presentation, 2026
Slide 26: Clientele
CLIENTELE Investor Presentation, 2025
Slide 27: ESG Initiatives
ESG INITIATIVES E • Zero Liquid Discharge (ZLD) • Carbon Footprint Reduction • Eco-friendly Packaging • Efficient Utilities & Green Technologies Environment S • Healthcare Initiatives •Woman • Fair Trade Practices • Gender Diversity Empowerment Social G • Stakeholder • Risk Management Governance • A
Slide 28: Leadership
LEADERSHIP RANJAN JAIN SUNINDER VEER SINGH SANJEEV AGRAWAL MANAGNG DIRECTOR WHOLE-TIME DIRECTOR CHIEF FINANCIAL OFFICER With over 25+ years of He oversees Sales and With around 30 years entrepreneurial Marketing, bringing over of experience in experience. Mr. Jain has two decades of finance, operati
Slide 29: Capital Market Information
CAPITAL MARKET INFORMATION Shareholding Pattern as on 31st March, 2026 Public Promoter and Promoter Group Particulars % Shareholding Promoter and Promoter Group 60.86% Public 39.14% TOTAL 100% 39.14% Market Indicators 60.86% Incorporated 1991 Listed on BSE BSE Scrip Code | NSE Symbol 531173 | SYSCHE
Slide 30: Safe Harbour Statement
SAFE HARBOUR STATEMENT This Information Memorandum has been prepared by the Company based on information and data which the Company considers reliable. However, the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on the truth, accuracy, re
Slide 31: Safe Harbour Statement
SAFE HARBOUR STATEMENT These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the wind power industry in India and worldwide, the Company's ability to successfully implement its st
Slide 32: Thank You
~ I N N O V AT I N G T O D AY F O R A H E A LT H I E R T O M O R R O W THANK YOU For further information contact www.syschem.in Head Office : 825, FF, NAC Manimajra , Chandigarh-161001 Factory at : Village Bargodam, Tehsil Kalka, Dist. Panchkula, Haryana-133302 0172-5070471 [email protected] Investor